Intravenous immunoglobulins and transforming growth factor β

Lancet

Volumn 351, Issue 9097, 1998, Pages 184-185

  Kekow, Jörn ^a   Reinhold, Dirk ^b   Pap, Thomas ^b   Ansorge, Siegfried ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBULIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; DISSOCIATION; DRUG ANALYSIS; DRUG STORAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL;

EID: 0032539438     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78212-X     Document Type: Article

References (5)

1. 1 Mouthon L, Kaveri SV, Spalter SH, et al. Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 1996; 104: 3-9.
2. 2 Szymkowiak C, Mons I, Gross WL, Kekow J. Determination of transforming growth factor β2 determination in human blood samples by ELISA. J Immunol Methods 1995; 184: 263-71.
3. 3 Pap T, Zimmerman E, Spieler W, Keitel W, Kekow J. Short-term efficacy of intravenous immunoglobulin therapy in patients with rheumatoid arthritis. In: Machtey I, ed. Progress in rheumatology. Petah Tiqva, Israel: Rheumatology Service, Golga Campus, 1996: 18-21.
4. 4 Stach RM, Rowley DA. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med 1993; 178: 841-52.
5. 5 Kekow J, Wiedemann GJ. Transforming growth factor β: a cytokine with multiple actions in oncology and potential clinical applications. Int J Oncol 1995; 7: 177-82.